Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: BridgeBio Pharma Inc., 3 years.
BridgeBio Pharma Inc.
Director
Maze Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 27, 2025 | BridgeBio Pharma Inc. | Gift | −20,000 | — | — |
| Jun 20, 2025 | BridgeBio Pharma Inc. | Grant or award | +6,589 | — | — |
| Feb 3, 2025 | Maze Therapeutics Inc. | Derivative conversion | +8,807 | — | — |
| Feb 3, 2025 | Maze Therapeutics Inc. | Derivative conversion | +20,717 | — | — |
| Feb 3, 2025 | Maze Therapeutics Inc. | Derivative conversion | +7,422 | — | — |
| Feb 16, 2024 | BridgeBio Pharma Inc. | Option exercise | +3,760 | — | — |
| Feb 16, 2024 | BridgeBio Pharma Inc. | Shares withheld for tax | −1,509 | $37.21 | $56,150 |
| Nov 16, 2023 | BridgeBio Pharma Inc. | Option exercise | +3,760 | — | — |
| Nov 16, 2023 | BridgeBio Pharma Inc. | Shares withheld for tax | −1,301 | $28.86 | $37,547 |
| Aug 16, 2023 | BridgeBio Pharma Inc. | Option exercise | +3,760 | — | — |
| Aug 16, 2023 | BridgeBio Pharma Inc. | Shares withheld for tax | −1,301 | $29.80 | $38,770 |
| May 16, 2023 | BridgeBio Pharma Inc. | Option exercise | +3,759 | — | — |
| May 16, 2023 | BridgeBio Pharma Inc. | Shares withheld for tax | −1,300 | $14.09 | $18,317 |
| Feb 16, 2023 | BridgeBio Pharma Inc. | Option exercise | +3,760 | — | — |
| Feb 16, 2023 | BridgeBio Pharma Inc. | Shares withheld for tax | −1,534 | $12.64 | $19,390 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.